- $835.21m
- $574.56m
- $333.79m
- 81
- 54
- 73
- 80
Annual cashflow statement for CareDx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18.7 | -30.7 | -76.6 | -190 | 52.5 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 27.7 | 43.5 | 54 | 50.9 | 73.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 18.4 | -39.6 | -14 | 106 | -102 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 33.4 | -19.3 | -25.2 | -18.4 | 38 |
Capital Expenditures | -10.4 | -20.3 | -24.3 | -9.24 | -6.48 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -90 | 68 | -204 | 49.7 | 6 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -100 | 47.7 | -229 | 40.4 | -0.483 |
Financing Cash Flow Items | -4.53 | -18.1 | -8.56 | -3.68 | -15.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 163 | 186 | -4.54 | -29.6 | -5.61 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 96.5 | 214 | -258 | -7.66 | 32.5 |